Search

Mobile technologies to support global ear and hearing care

By combining mobile technology with artificial intelligence, more people can access ear and hearing care. The World Health Organization (WHO) estimates that worldwide, nearly half a billion people have moderate or worse hearing loss [1]. The vast majority of people...

Mobile technologies to support global ear and hearing care

By combining mobile technology with artificial intelligence, more people can access ear and hearing care. The World Health Organization (WHO) estimates that worldwide, nearly half a billion people have moderate or worse hearing loss [1]. The vast majority of people...

Practising surgery in a war zone: an interview with Dr Volodymyr Melnyk

It is now nine months since the full-scale Russian invasion of Ukraine commenced in late February 2022, with Putin announcing a “special military operation” to “denazify and demilitarise” Ukraine. The rest of the world, however, saw it for what it...

Genomic testing for deafness and its implications

Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...

In conversation with Prof Helge Rask-Andersen: on cell regeneration and treatment of human deafness

Helge Rask-Andersen, head of the inner ear research laboratory at the University of Uppsala in Sweden, has many achievements to his name. He was made an Honorary Member of ENT UK earlier this year. Gerry O’Donoghue caught up with him...

Health related quality of life measures as outcome parameters in middle ear diseases

Surely the only outcome needed for post-surgical ears is a better PTA? Marcus Neudert argues there should be more to it than that. To draw a comprehensive picture of the disease-associated restrictions in patients with chronic otitis media, audiometric outcome...

Current management of unilateral sporadic vestibular schwannoma

Vestibular schwannoma is the commonest tumour of the cerebellopontine angle (80%) and accounts for around 8% of all intracranial tumours. The commonest primary presenting symptoms are audio vestibular. Hearing health professionals are often the first contact for patients with potential symptoms of vestibular schwannoma, with the majority then being seen and diagnosed by otorhinolaryngologists.

COVID-19 in China: the experience of an ENT team

In January, we first heard of COVID-19. As we currently do battle with it on our own shores, colleagues in China share their story with us as life there slowly and cautiously begins to return to normal and the country...